Trinity Biotech (TRIB) Current Assets (2016 - 2025)
Trinity Biotech's Current Assets history spans 17 years, with the latest figure at $35.9 million for Q4 2025.
- On a quarterly basis, Current Assets fell 12.7% to $35.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.9 million, a 12.7% decrease, with the full-year FY2025 number at $35.9 million, down 12.7% from a year prior.
- Current Assets hit $35.9 million in Q4 2025 for Trinity Biotech, up from $33.0 million in the prior quarter.
- Over the last five years, Current Assets for TRIB hit a ceiling of $87.6 million in Q1 2021 and a floor of $33.0 million in Q2 2025.
- Historically, Current Assets has averaged $54.1 million across 5 years, with a median of $48.3 million in 2022.
- Biggest five-year swings in Current Assets: rose 29.85% in 2021 and later plummeted 36.31% in 2022.
- Tracing TRIB's Current Assets over 5 years: stood at $72.7 million in 2021, then plummeted by 35.8% to $46.7 million in 2022, then fell by 16.34% to $39.0 million in 2023, then increased by 5.34% to $41.1 million in 2024, then dropped by 12.7% to $35.9 million in 2025.
- Business Quant data shows Current Assets for TRIB at $35.9 million in Q4 2025, $33.0 million in Q2 2025, and $41.1 million in Q4 2024.